Fluid attenuation in non-contrast-enhancing tumor (nCET): an MRI Marker for Isocitrate Dehydrogenase (IDH) mutation in Glioblastoma.

Sohil H PatelPrem P BatchalaThomas J Eluvathingal MuttikkalSergio S FerranteJames T PatrieCamilo E FadulDavid SchiffM Beatriz LopesRajan Jain

Published in: Journal of neuro-oncology (2021)

Conventional MRI metrics and patient age predict IDH-mutation status in glioblastoma. Among MRI markers, fluid attenuation in nCET represents a novel marker with high inter-reader agreement that is strongly associated with Glioblastoma, IDH-mutant.

Keyphrases

contrast enhanced
wild type
magnetic resonance imaging
low grade
diffusion weighted imaging
magnetic resonance
computed tomography
case report